Tuberculosis Testing Market: By Test Type, Interferon Gamma Release Analysis, Nucleic Acid Testing, Sear Microscopy, Serological Tests), By End User, and Geography
Tuberculosis Testing Market size was valued at US$ 3.02 billion in 2023 and is poised to grow at a CAGR of 4.5% from 2024-2030. Tuberculosis is a bacterial infectious disease caused by Mycobacterium tuberculosis (MTB). Tuberculosis spreads through air and direct contact with the infected sputum. Tuberculosis usually affects lungs. But it can affect any other parts of the body. Tuberculosis patient generally experiences symptoms such as cough, chills, fever, fatigue, loss of weight and others. TB infecting bones can lead to joint destruction or spinal pain.
The most common diagnostic test used for TB is skin test, but it is not fully accurate. There are many tuberculosis tests are available such as bloodstream test, sputum tests, and Chest X-rays.The tuberculosis testing market is consolidated with the presence of strong market key players involving in development and marketing of the tuberculosis tests. Companies adopting the strategies such as mergers and acquisitions to strengthen their market position and expand their global reach. Furthermore, market layers also developing new testing technologies and novel products to increase their market share.
Study Period
2024-2030Base Year
2023CAGR
4.5%Largest Market
North AmericaFastest Growing Market
Europe
Primary drivers for the global tuberculosis testing market include the rise in the disease prevalence worldwide. In addition, technological advancements in tuberculosis testing such as advent of test kits and point of care products are expected to boost the global tuberculosis testing market over the forecast period. Furthermore, government initiatives for early detection and of tuberculosis coupled with an increase in adaptation of the point of care products for tuberculosis diagnosis are expected to boost the market growth over the forecast period. However, R&D cost for the development of the novel testing procedures for TB expected to hamper the market growth over the coming years.
Geographically tuberculosis testing market is divided into five key regions, i.e. Europe, North America, Latin America, Asia- Pacific, and The Middle East & Africa. North America tuberculosis testing market expected to have the significant market share owing to the presence of key market players, and developed healthcare infrastructure. Furthermore, market is witnessing recent product launched and strategical collaboration and acquisitions especially in U.S. For instance, In October 2017, Qiagen has launched QuantiFERON TB Gold Plus, blood test for the tuberculosis (TB) infections in U.S. market. Europe tuberculosis testing market expected to show notable growth rates owing to the prevalence of tuberculosis, technological advancements in the diagnostic tests coupled with the growing awareness related to early diagnosis and treatment of TB. World Health Organization, estimates that about 323000 new TB cases were reported in the Europe, in 2015. Asia Pacific tuberculosis testing market is projected to have lucrative growth opportunity due to the disease prevalence, developing healthcare infrastructure and initiatives taken by the government to increase awareness and funding for early detection of tuberculosis.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 3.02 billion |
|
Market CAGR |
4.5% |
|
By Test Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The Tuberculosis Testing Market size was valued at US$ 3.02 billion in 2023 and is poised to grow at a CAGR of 4.5% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Tuberculosis Testing Market Introduction |
| 2.1.Global Tuberculosis Testing Market - Taxonomy |
| 2.2.Global Tuberculosis Testing Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3. Global Tuberculosis Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Tuberculosis Testing Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Tuberculosis Testing Market By Test Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Culture Based Tests |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mantoux Test (TST) |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Interferon Gamma Release Analysis (IGRA) |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Nucleic Acid Testing |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Sear Microscopy |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Serological Tests |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Tuberculosis Testing Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diagnostic Centres |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Tuberculosis Testing Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Culture Based Tests |
| 8.1.2.Mantoux Test (TST) |
| 8.1.3.Interferon Gamma Release Analysis (IGRA) |
| 8.1.4.Nucleic Acid Testing |
| 8.1.5.Sear Microscopy |
| 8.1.6.Serological Tests |
| 8.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Diagnostic Centres |
| 8.2.3.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Culture Based Tests |
| 9.1.2.Mantoux Test (TST) |
| 9.1.3.Interferon Gamma Release Analysis (IGRA) |
| 9.1.4.Nucleic Acid Testing |
| 9.1.5.Sear Microscopy |
| 9.1.6.Serological Tests |
| 9.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Diagnostic Centres |
| 9.2.3.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Culture Based Tests |
| 10.1.2.Mantoux Test (TST) |
| 10.1.3.Interferon Gamma Release Analysis (IGRA) |
| 10.1.4.Nucleic Acid Testing |
| 10.1.5.Sear Microscopy |
| 10.1.6.Serological Tests |
| 10.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Diagnostic Centres |
| 10.2.3.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Culture Based Tests |
| 11.1.2.Mantoux Test (TST) |
| 11.1.3.Interferon Gamma Release Analysis (IGRA) |
| 11.1.4.Nucleic Acid Testing |
| 11.1.5.Sear Microscopy |
| 11.1.6.Serological Tests |
| 11.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Diagnostic Centres |
| 11.2.3.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Tuberculosis Testing Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Culture Based Tests |
| 12.1.2.Mantoux Test (TST) |
| 12.1.3.Interferon Gamma Release Analysis (IGRA) |
| 12.1.4.Nucleic Acid Testing |
| 12.1.5.Sear Microscopy |
| 12.1.6.Serological Tests |
| 12.2. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Diagnostic Centres |
| 12.2.3.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Hologic, Inc. |
| 13.2.2.Thermo Fisher Scientific, Inc. |
| 13.2.3.Becton, Dickinson and Company |
| 13.2.4.Abbott Laboratories |
| 13.2.5.bioMerieux SA |
| 13.2.6.Hoffmann-La Roche AG |
| 13.2.7.Cepheid |
| 13.2.8.Sanofi S.A. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
